Vicapsys Life Sciences, Inc. (VICP)

USD 7.0

(0.0%)

Total Liabilities Summary of Vicapsys Life Sciences, Inc.

Vicapsys Life Sciences, Inc.'s latest annual total liabilities in 2023 was 1.96 Million USD , up 92.44% from previous year.
Vicapsys Life Sciences, Inc.'s latest quarterly total liabilities in 2023 Q1 was 1.2 Million USD , up 17.78% from previous quarter.
Vicapsys Life Sciences, Inc. reported annual total liabilities of 1.02 Million USD in 2022, up 42.86% from previous year.
Vicapsys Life Sciences, Inc. reported annual total liabilities of 715.96 Thousand USD in 2021, down -16.09% from previous year.
Vicapsys Life Sciences, Inc. reported quarterly total liabilities of 1.47 Million USD for 2023 Q2, up 22.17% from previous quarter.
Vicapsys Life Sciences, Inc. reported quarterly total liabilities of 1.2 Million USD for 2023 Q1, up 17.78% from previous quarter.

Annual Total Liabilities Chart of Vicapsys Life Sciences, Inc. (2023 - 2008)

Historical Annual Total Liabilities of Vicapsys Life Sciences, Inc. (2023 - 2008)

Year	Total Liabilities	Total Liabilities Growth
2023	1.96 Million USD	92.44%
2022	1.02 Million USD	42.86%
2021	715.96 Thousand USD	-16.09%
2020	853.22 Thousand USD	115.2%
2019	396.48 Thousand USD	-62.24%
2018	1.05 Million USD	1.98%
2017	1.02 Million USD	0.0%
2009	4.96 Million USD	94.6%
2008	2.55 Million USD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2023 Q4	1.96 Million USD	27.62%
2023 Q2	1.47 Million USD	22.17%
2023 Q1	1.2 Million USD	17.78%
2023 Q3	1.54 Million USD	4.8%
2022 Q4	1.02 Million USD	13.13%
2022 Q3	904.07 Thousand USD	6.51%
2022 Q1	765.81 Thousand USD	6.96%
2022 Q2	848.79 Thousand USD	10.84%
2022 FY	1.02 Million USD	42.86%
2021 Q4	715.96 Thousand USD	-4.03%
2021 FY	715.96 Thousand USD	-16.09%
2021 Q3	746.04 Thousand USD	-9.15%
2021 Q2	821.18 Thousand USD	-0.61%
2021 Q1	826.19 Thousand USD	-3.17%
2020 Q3	783.92 Thousand USD	10.3%
2020 Q4	853.22 Thousand USD	8.84%
2020 Q2	710.71 Thousand USD	37.17%
2020 Q1	518.13 Thousand USD	30.68%
2020 FY	853.22 Thousand USD	115.2%
2019 Q3	404.09 Thousand USD	0.0%
2019 FY	396.48 Thousand USD	-62.24%
2019 Q4	396.48 Thousand USD	-1.88%
2019 Q1	- USD	-100.0%
2018 Q4	1.05 Million USD	0.0%
2018 FY	1.05 Million USD	1.98%
2017 FY	1.02 Million USD	0.0%
2010 Q2	7.71 Million USD	71.43%
2010 Q1	4.5 Million USD	90540.4%
2009 Q4	4964.74 USD	0.0%
2009 FY	4.96 Million USD	94.6%
2008 FY	2.55 Million USD	0.0%

Peer Total Liabilities Comparison of Vicapsys Life Sciences, Inc.

Name	Total Liabilities	Total Liabilities Difference
America Great Health	4.82 Million USD	59.205%
Gene Biotherapeutics, Inc.	- USD	-Infinity%
Evolutionary Genomics, Inc.	7.94 Million USD	75.227%
Innovation1 Biotech Inc.	3.5 Million USD	43.857%
Point of Care Nano-Technology, Inc.	266.41 Thousand USD	-638.826%